Corient Private Wealth
OMCL icon

Corient Private Wealth’s Omnicell OMCL Stock Holding History

Corient Private Wealth’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
62,809
+20,000
+47% +$806K ﹤0.01% 1224
2026
Q1 		$1.43M Buy
+42,809
New +$1.79M ﹤0.01% 1444
2023
Q4 		– Sell
-4,858
Closed -$219K – 2322
2023
Q3 		$219K Buy
4,858
+626
+15% +$37.9K ﹤0.01% 1878
2023
Q2 		$312K Buy
4,232
+274
+7% +$18.5K ﹤0.01% 1676
2023
Q1 		$232K Buy
+3,958
New +$218K ﹤0.01% 1728

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Corient Private Wealth's OMCL Position: Q2 2026 in Review

Corient Private Wealth increased its Omnicell (OMCL) stake by 47% in Q2 2026, buying an estimated $806K and bringing the position to 62,809 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1224.

Corient Private Wealth first reported a position in OMCL in Q1 2023 and has held it in 5 quarters since. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Corient Private Wealth held 62,809 shares of Omnicell worth $2.61M as of Q2 2026.
  • Corient Private Wealth bought 20,000 Omnicell shares in Q2 2026, an estimated $806K.
  • Omnicell made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1224 holding.
  • Corient Private Wealth first reported a position in Omnicell in Q1 2023 and has held it in 5 quarters since.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.